Deal Flow
+
Deal Flow +
Global Item-Level SaaS AI Payment Infrastructure Acquisition Opportunity - A New Payments Rail | $800M to $1B ($1B Unsolicited Offer Received)
Embedded at Scale: Integrated inside 50%+ of U.S. retail POS ecosystems, enabling item-level connectivity across a substantial share of national brick-and-mortar volume.
Irreplicable Data Rail. Owns the critical bridge between retailers, payments and the in-store basket — infrastructure, not a feature. Blockchain native. Fully auditable payments between any two parties.
Strategic Control Point. Creates a toll-booth position for payment networks, processors, and Big Tech seeking secure access to item-level commerce, omnichannel distribution and settlement in any medium. Buy it now or rent it for the rest of time.
Cybersecurity Buy-Side | Up to $50M
Targeting MSP/MSSP providers with recurring revenue, 24/7 SOC capabilities, MDR/XDR offerings, and strong client retention in regulated industries.
Seeking cybersecurity companies focused on CMMC, NIST, HIPAA, PCI, and other regulatory frameworks serving federal, defense, healthcare, and financial services clients.
Interest in firms providing penetration testing, red teaming, incident response, digital forensics, vulnerability management, and threat intelligence services.
Cyber advisory, cloud security architecture, zero-trust implementation, identity & access management (IAM), and DevSecOps teams with scalable talent models and strong backlog visibility..
COMING SOON! AI Intelligence Funds II and III | $300M
FX Quant Fund: No market or timing risk. Completely uncorrelated to any market. An AI-first, human-governed approach balancing speed with oversight, delivering consistently positive returns across diverse market conditions, focused on capturing small foreign exchange pricing differences between markets.
Fund I: $392.9M balance as of 12/31/2025. Operating 40 months. Average unweighted monthly NET return 7.07%. Zero negative monthly returns.
Two new options: Choose between standard 2% management fee + 20% performance carry OR 2% net monthly return with a catch-up feature to recover prior down months.
Disclaimer: The fund names used above are fictitious. Actual fund names and full due diligence materials will be available after all required approvals for Funds II & III are in place. This is provided for informational purposes only. It does not constitute an offer to sell or a solicitation of an offer to buy any security. Past performance is not indicative of future results. Investments involve risks, including loss of principal and can only be made to Accredited Investors through the offering documents, when availale.
Advanced Wound Care | $5M Co-Invest
$500M US-based life sciences tissue supplier committed to improving human and planetary health is seeking a profitable for-profit partner to commercialize a new skin substitute technology to address the market cliff created by the CMS reduction in CAMPs reimbursements from $1,000+ per square centimeter to $127 per cm2.
Several years of research have produced an innovative wound care solution designed to reduce dressing changes and improve overall patient outcomes in Negative Pressure Wound Treatments (NPWTs).
The only technology designed to incorporate the benefits of an advanced skin substitute and NPWT in one dressing
AI Real Estate Image Tech | $3M
In real estate sales, images sell! As a professional realtor, high-quality photos and videos of listings mean faster sales, higher selling prices, higher commissions. Highest quality images - still, video and drone - set to music, delivered in 24-36 hours.
Biospring Fund II | $100M close-out
Fund I has $168.4M out of $250M invested. The fund has an unrealized value of $228.4M with a gross/net MOIC of 1.4x/1.2x, a gross/net IRR of 17%/7% and a 0.10x DPI. The fund has successfully invested in seven technology-enabled, EBITDA-positive B2B pharma services businesses.
Biospring Fund I performance: To 25% relative to peer 2021 vintage funds based on Pitchbook data as of 4Q 2024.
Fund II has raised $250M in commitments and will close out at $350M.
Leveraging the deal flow from Fund I, Fund II also invests in technology-enabled, EBITDA-positive B2B pharma services
businesses in areas including outsourced complex biomanufacturing and outsourced clinical trials services.
Fund II: Management funded 10% of fund in cash, No management fee, No carry co-invest, No binary risk (e.g., product, regulatory, reimbursement)
Fund II Target: 2-3x Net MOIC and 25% Net IRR
Diversified Media Platform | $12M Equity Capital Raise
Leadership team is leveraging the tech that built a $1B revenue medical staffing firm to build audience engagement in the entertainment industry.
Completed projects include a prestige feature film starring Al Pacino, a sports documentary starring Cam Ward and two psychological thrillers.
Creative partnerships with Iconic Arts, Scary Markets/tZero, Spooky Pictures (Steven Schneider and Roy Lee), .
Future projects include 00Khaby, Outer Space, Death Valley, Pathetic Fallacy
Targeting valuation similar to A24, Neon, Range and Angel Studios.
Al Pacino! >>>
CNS & Acute Care Biopharma Platform
FDA-Approved Acute Care Asset – U.S. commercial-stage, hospital-based pain therapy with established formulary access, CMS reimbursement pathway, meaningful remaining IP protection, ex-US licenses in place generating revenue. Over $100M invested, available at a very attractive price.
Phase II Neurology Pipeline Candidate – Differentiated small-molecule CNS asset targeting a validated pathway in epilepsy and related neurologic disorders; completed proof-of-concept with expansion potential across multiple indications.
Additional CNS Pipeline Therapies – Early-stage assets providing longer-term optionality and platform-level strategic value.
Luxury Car Storage & Lifestyle Development (Car Condo) | $4M
Southeast U.S. | Real Estate Development Opportunity
Proven concept with two completed projects. Seeking new capital partner.
Multiple premium auto-related partners and sponsors in place.
A resort-like community for car collectors and motorsports enthusiasts.
Total development cost ~$11M. Groundbreaking to final sale estimated at 36 months. 12% pref, then 50/50 split generating projected 69% IRR and 1.6x MOIC.
The Royal St. David’s Hotel | $5M
The Jewel of North Wales
Planned 80–100 room luxury resort & spa with 35 rental cottages directly overlooking Royal St. David’s Golf Club, one of only 64 “Royal” courses globally.
Walking distance to Harlech Castle & Harlech Beach. Short drive to Wrexham, home of Ryan Reynold’s WrexhamAFC soccer club.
$15 million+ land contribution from partners
Targeting 2-5x+ return on equity within 5-7 year development period.
Sample Closed Transactions
CLOSED! Sell-side M&A Leading Energy Digital Marketing Firm
PRICE NOT DISCLOSED
20+ year provider of digital content, digital marketing strategies and campaigns, and omni digital channel deployment for 200+ top North American energy providers. The industry leader in driving engagement, interaction, and program participation across the utility sector.
CLOSED! $55 Million Equity Commitment
AI-Driven Micro-Grid solutions Company
This company has developed an AI-driven, scaled-down version of an industrial solar/NG generator-battery-grid electric system. The system takes an 'Energy as a Service' (EaaS) approach to generate a continuous and reliable power source on-site, either in parallel with the grid or on a stand-alone basis. Currently, these systems are an option only for industrial and large commercial sites - scaled to 5000 sf credit-grade end users. The Company’s key innovation is bringing it down to the size and scale that can be effectively deployed and managed at a very small scale.
CLOSED! Series A Equity Investment UCaaS
UCaas/Saas platform - unified communications as a service -
READ AND DOWNLOAD THE PRESS RELEASE HERE
Profitable, highly scalable UCaaS (Unified Communications as a Service) combining phone, SMS, chat, email, & social media in a single seamless interface. Reduces customer service calls by 50-60% and includes an almost 100% margin mobile payments function. Substantial increase in ‘first contact resolution’ using each customer’s channel of choice.